2013-11-11T16:07:04-06:00 2012-12-31 341874260 CBIZ MHM LLC 11440 TOMAHAWK CREEK PARKWAY LEAWOOD KS 66211 990 2012-01-01 431889037 KANSAS CITY AREA LIFE SCIENCES INSTITUTE INC KANS 8167537700 30 W PERSHING ROAD NO 210 KANSAS CITY MO 64108 WAYNE O CARTER 8167537700 2013-10-28 1 9132341000 2012 2016-03-07 17:11:31Z WAYNE O CARTER 30 W PERSHING ROAD NO 210 KANSAS CITY MO 64108 1568177 0 X WWW.KCLIFESCIENCES.ORG X 2000 MO THE PURPOSE OF THIS ORGANIZATION IS TO PROMOTE AND FOSTER DEVELOPMENT OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA AND TO PROVIDE A PLATFORM FOR DEVELOPMENT AND COOPERATION IN THE AREA OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA. 13 12 5 46 0 0 1655199 1508320 147105 59718 36 -4878 76 100 1802416 1563260 200000 251491 0 0 514772 558857 0 0 101362 895959 686623 1610731 1496971 191685 66289 755275 821564 0 0 755275 821564 X THE PURPOSE OF THIS ORGANIZATION IS TO PROMOTE AND FOSTER DEVELOPMENT OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA AND TO PROVIDE A PLATFORM FOR DEVELOPMENT AND COOPERATION IN THE AREA OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA. 0 0 1139112 251491 54901 SEE SCHEDULE O 1139112 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 5 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 X 13 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 1 1 0 0 X X SHARON NEWMAN 8167537700 30 W PERSHING ROAD STE 210 KANSAS CITY MO 64108 IRVINE O HOCKADAY JR 0.50 X 0 0 0 ROBERT A KIPP 0.50 X X 0 0 0 FRED LOGAN 0.50 X 0 0 0 ANNE D ST PETER 0.50 X 0 0 0 L PATRICK JAMES 2.00 X X 0 0 0 MICHAEL HELMSTETTER 0.30 X 0 0 0 WILLIAM S BERKLEY 0.10 X 0 0 0 THOMAS A MCDONNELL 0.30 X 0 0 0 DONALD CRAIG BRATER 0.10 X 0 0 0 STEPHEN REINTJES 0.30 X 0 0 0 DANIEL P GETMAN 40.00 X X 122491 0 19816 WAYNE O CARTER 40.00 X X 116526 0 5341 DAVID FRANTZE 0.30 X 0 0 0 ROBERT D REGNIER 0.30 X 0 0 0 DEBORAH WILKERSON 0.10 X 0 0 0 KEITH A GARY 40.00 X 147880 0 17310 386897 0 42467 3 0 1 0 0 1508320 1508320 LIFE SCIENCES DINNER 900099 37440 37440 ANIMAL HEALTH SYMP. 900099 22278 22278 59718 39 39 4917 -4917 -4917 -4917 OTHER INCOME 900099 100 100 100 1563260 54901 0 39 X 251491 251491 264174 132087 79252 52835 226122 157555 42997 25570 34999 18480 11493 5026 33562 19737 8547 5278 218264 160455 57809 82439 82189 170 80 36071 18928 12977 4166 18335 7228 11107 40238 16286 15545 8407 27415 22765 4650 25762 25762 4165 4165 OTHER SCIENCE INIT. 99415 99415 0 0 ANNUAL MTG & LIFE SCI. 95060 95060 0 0 HONORARIA 13500 13500 0 0 ADVISORY BOARD 10758 9400 1358 0 15201 8774 6427 1496971 1139112 256497 101362 308345 224715 433942 588287 118235 109673 12988 8562 755275 821564 0 0 X 555275 621564 200000 200000 755275 821564 755275 821564 66289 0 X 0 1 X 1 1 1 X X X X 0 0 0 GREATER KC COMM FNDTN 431152398 COMMUNITY TRUST 1 1 1 0 1 0 SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: SUPPORT PROVIDED PART I, LINE 11H (VII) KCALSI PROVIDED TO THE GREATER KANSAS CITY COMMUNITY FOUNDATION ADVICE WITH RESPECT TO DONOR-ADVISED FUNDS AND COORDINATED DONOR EDUCATION EVENTS. NO MONETARY SUPPORT WAS PROVIDED. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 2681 2681 1139112 1141793 189179 47295 0 0 252784 236211 203792 189179 881966 1322949 0 0 0 2681 2681 63196 59053 50948 47295 220492 330738 0 0 0 0 43886 35324 8562 74349 74349 0 8562 X 1563260 0 1563260 0 1563260 1496971 0 1496971 0 1496971 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: TAXES - KANSAS CITY AREA LIFE SCIENCES INSTITUTE, INC. HAS BEEN GRANTED AN EXEMPTION FROM INCOME TAXES BY THE INTERNAL REVENUE SERVICE UNDER THE PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THERE WAS NO UNRELATED BUSINESS INCOME DURING 2012 OR 2011 FOR THE ENTITY. THE INSTITUTE HAS EVALUATED THE STANDARDS REQUIRING DISCLOSURE OF UNCERTAIN TAX POSITIONS UNDER FASB ASC 740, INCOME TAXES, AND DETERMINED THAT THERE ARE NO MATTERS WHICH MERIT DISCLOSURE. 1 KU MEDICAL CENTER RESEARCH INSTITUTE INC 3901 RAINBOW BLVD KANSAS CITY KS 66160 481108830 501(C)(3) 150000 KCALSI-12-1 BLUE KC OUTCOMES RESEARCH GRANT EDWARD ELLERBECK, MD; KCALSI-12-3 PATTON TRUST GRANT TIMOTHY FIELDS; KCALSI-12-5 PATTON TRUST GRANT BRIAN PETROFF MIDWEST BIOMEDICAL RESEARCH FOUNDATION 4801 LINWOOD BLVD KANSAS CITY MO 64128 431496422 501(C)(3) 50000 KCALSI-12-2 BLUE KC OUTCOMES RESEARCH GRANT CHILDREN'S MERCY HOSPITAL 2401 GILLHAM ROAD KANSAS CITY MO 64108 440605373 501(C)(3) 50000 KCALSI-12-4 PATTON TRUST GRANT STEPHEN KINGSMORE 3 0 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: GRANTS ARE FOR A ONE YEAR DURATION. GRANT RECIPIENTS AGREE TO PROVIDE A PROGRESS REPORT AT SIX MONTHS AND A SUMMARY TECHNICAL PROGRESS REPORT WITHIN 30 DAYS OF THE END OF THE PERFORMANCE TO INCLUDE: 1. A BRIEF SUMMARY OF TECHNICAL PROGRESS RELATIVE TO THE GOALS AND OBJECTIVES PROPOSED IN THE PROPOSAL. 2. A BRIEF STATEMENT CONCERNING THE EFFECTIVENESS AND BENEFITS REALIZED FROM THE COLLABORATIONS INVOLVED. GRANT RECIPIENTS AGREE TO PROVIDE (UPON REQUEST) A COPY OF ALL PROPOSALS SUBMITTED TO EXTERNAL FUNDING AGENCIES AS A RESULT OF THE SUPPORT PROVIDED AND SUBSEQUENTLY NOTIFY KCALSI OF ACCEPTANCE OR REJECTION THEREOF. IF THE GRANT RECIPIENT RECEIVES ALTERNATIVE FUNDS FOR SUPPORT OF THIS SPECIFIC PROJECT, KCALSI REQUESTS THAT THE RECIPIENT RETURN ANY UNEXPENDED FUNDS TO THE INSTITUTE SO THAT THEY CAN BE USED TO SUPPORT OTHER INVESTIGATORS. X X 0 0 0 0 0 0 0 0 0 KEITH A GARY 147880 0 0 0 0 0 14970 0 2340 0 165190 0 0 0 FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: FORM 990, PART III, LINE 4A 2012 ACCOMPLISHMENTS: -PROGRESS ON THE CHAMBER'S BIG 5 IDEAS FOR THE REGION, THREE OF WHICH WE ARE ACTIVELY INVOLVED AND COMMITTED TO SUCCESS: 1) GROWING KANSAS CITY'S MEDICAL RESEARCH FROM DISCOVERY TO CURE, CHAMPIONED BY KCALSI CHAIRMAN DR. PATRICK JAMES, SR. MANAGING PARTNER, QUEST DIAGNOSTICS; THIS INITIATIVE HAS THREE COMPONENTS: A. NCI DESIGNATION WAS RECEIVED IN JULY 2012 AND WAS A SIGNIFICANT REGIONAL WIN FOR HEALTH CARE, CANCER RESEARCH AND PATIENTS EVERYWHERE. B. LEVERAGING THE $20 MILLION NIH CLINICAL AND TRANSLATIONAL SCIENCE AWARD GRANT TO FRONTIERS: THE HEARTLAND INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH BASED AT THE UNIVERSITY OF KANSAS MEDICAL CENTER AND INVOLVES 3 MEDICAL CENTERS, 10 HEALTH SYSTEMS AND 15 COMMUNITY PARTNERS. THIS IS A UNIQUE, BI-STATE COLLABORATION THAT SERVES AS A FOUNDATION FOR GROWING THIS SECTOR. SEVERAL KCALSI STAKEHOLDERS ARE IMPORTANT CONTRIBUTORS AND MEMBERS OF THE FRONTIERS COLLABORATIVE NETWORK INCLUDING; CHILDREN'S MERCY HOSPITALS AND CLINICS, KANSAS CITY UNIVERSITY OF MEDICINE AND BIOSCIENCES, SAINT LUKE'S HEALTH SYSTEM, TRUMAN MEDICAL CENTER, THE UNIVERSITY OF KANSAS AND THE MEDICAL CENTER, UNIVERSITY OF MISSOURI KANSAS CITY. IN ADDITION TO BROAD SUPPORT OF THE CTSA/FRONTIERS PROGRAM, KCALSI ALSO PRESENTS AN ANNUAL HUMAN TRANSLATIONAL RESEARCH SYMPOSIUM WITH FRONTIER LEADERS AND HAS BROUGHT THE WOODROW WILSON FOUNDATION TO THE TABLE FOR A POST-DOC FELLOWSHIP PROGRAM. KCALSI IS ALSO COORDINATING REGIONAL TRANSLATIONAL MEDICINE MEETINGS OF ALL STAKEHOLDERS TO INITIATE SCIENTIFIC NETWORKING AND COLLABORATION. C. DEVELOPING A FUNDING MECHANISM TO SUPPORT A WORLD-CLASS INSTITUTE FOR TRANSLATIONAL MEDICINE (ITM). SIGNIFICANT PROGRESS HAS BEEN MADE WITH ORGANIZATIONAL GROUPS TO BRING THE ITM TO FRUITION. EDUCATION EFFORTS HAVE FOCUSED ON OUR DESCRIPTION OF "NEXT GENERATION MEDICINE" TO MORE SPECIFICALLY COMMUNICATE THE OPPORTUNITY FOR VOTERS. THE ITM IS ENVISIONED AS A WORLD-CLASS SCIENTIFIC RESEARCH ORGANIZATION THAT WILL TRANSLATE BASIC RESEARCH DISCOVERIES INTO CLINICAL APPLICATIONS AND COMMERCIAL PRODUCTS. IT WILL BUILD UPON THE ONGOING REGIONAL EFFORT AND EXPAND, BUT NOT DUPLICATE, CURRENT CAPABILITIES. 2) A WORLD SYMPOSIUM ON ANIMAL HEALTH, LEVERAGING THE ANIMAL HEALTH CORRIDOR AND CHAMPIONED BY GARY FORSEE, SUPPORTED BY JIM HEETER, PRESIDENT AND CEO OF THE KC CHAMBER, AND BOB MARCUSSE, PRESIDENT AND CEO OF KC AREA DEVELOPMENT COUNCIL. KCALSI IS ASSISTING IN THE SYMPOSIUM DEVELOPMENT AND WE HOPE TO INTEGRATE OUR ANNUAL ANIMAL HEALTH RESEARCH SYMPOSIUM WITH THE WORLD SYMPOSIUM ON ANIMAL HEALTH. 3) MAKING KANSAS CITY, "AMERICA'S MOST ENTREPRENEURIAL CITY" - CHAMPIONED BY PETER DESILVA, CHAIRMAN & CEO, UMB BANK. IN 2012, KCALSI SUPPORTED AN I6 GRANT SUBMITTED BY UMKC THAT WAS AWARDED AND LED TO THE LAUNCH OF "DIGITAL SANDBOX" IN JANUARY 2013. THE GOAL IS TO CREATE 10 STARTUP COMPANIES WITHIN 2 YEARS WITH AT LEAST $1M IN REVENUE OR FOLLOW-ON INVESTMENT. ADDITIONALLY THE INSTITUTE FOR TRANSLATIONAL MEDICINE IS ALSO ENVISIONED TO BE COMMERCIALIZING AND LICENSING TECHNOLOGY INSTITUTE. -BIORESEARCH CENTRAL FORMATION AND PRESENTATION OF THE FIRST ANNUAL SUMMIT. A STUDY WAS COMMISSIONED BY THE KBA, KANSASBIO, KCALSI AND THE KCADC AND ILLUSTRATED THAT THE GREATER KANSAS CITY REGION IS HOME TO OVER 90 CONTRACT RESEARCH ORGANIZATIONS (CROS) AND CONTRACT SERVICE PROVIDERS (CSPS), EMPLOYING OVER 9,000 EMPLOYEES AND GENERATING OVER $1 BILLION IN ANNUAL REVENUE. A SECOND STUDY, CONDUCTED BY THE TUFTS UNIVERSITY CENTER FOR THE STUDY OF DRUG DEVELOPMENT (THE PREMIER PHARMACEUTICAL BENCHMARKING INSTITUTION) CATEGORIZED THE GREATER KC REGION AS A TOP 5 IN THE US IN EXPERTISE AND TOP 15 IN THE US IN SIZE. THE FIRST ANNUAL SUMMIT FOR THE REGIONAL CRO/CSP INDUSTRY WAS HELD IN NOVEMBER 2012 AND WITH BI-STATE SUPPORT WAS PRESENTED BY KCALSI, KANSASBIO AND MOBIO. OVER 240 PEOPLE ATTENDED THE SYMPOSIUM THAT ALSO FEATURED 42 INDUSTRY EXHIBITORS. ADDITIONALLY, NETWORKING EVENTS AND TRAINING PROGRAMS THROUGHOUT THE YEAR FUNCTION TO COALESCE THE NETWORK AND CREATE AN INFRASTRUCTURE THAT ACCELERATES REGIONAL DRUG AND MEDICAL DEVICE DEVELOPMENT. KCALSI WILL CONTINUE TO FUNCTION AS CONVENER OF THE ADVISORY BOARD AND ENSURE OPERATIONAL SUCCESS FOR THE PROGRAM WITH A GOAL TO DOUBLE THE REGIONAL INDUSTRY WITHIN 5 YEARS. -RESEARCH GRANT PROGRAMS KCALSI HAS ADMINISTERED RESEARCH GRANTS FOR SEVERAL YEARS. RESEARCH GRANTS ARE AWARDED TO GENERATE INITIAL RESULTS AND STIMULATE THE SUBMISSION OF MAJOR MULTIDISCIPLINARY RESEARCH PROPOSALS TO GOVERNMENT OR PRIVATE AGENCIES. APPLICANTS, REGARDLESS OF WHETHER THEY RECEIVE FUNDING OR NOT, RECEIVE PEER-REVIEWED FEEDBACK THAT IS USED TO IMPROVE FUTURE GRANT APPLICATIONS. THIS IS HIGHLY VALUED BY OUR STAKEHOLDERS. FROM 2006 TO 2011, THE KCALSI PROGRAM HAS MANAGED 47 GRANTS TOTALING $1,820,902 MILLION, WHICH ENABLED AREA RESEARCHERS TO SUCCESSFULLY COMPETE FOR $10,976,000 MILLION IN ADDITIONAL FUNDING. IMPORTANTLY, GRANTS TOTALING AN ADDITIONAL $9,003,343 MILLION ARE CURRENTLY WAITING FOR FINAL FUNDING DECISIONS. KCALSI PARTNERED WITH BLUE CROSS AND BLUE SHIELD OF KANSAS CITY TO MANAGE ITS "BLUE KC HEALTH OUTCOMES RESEARCH GRANTS." KCALSI ISSUED THE RFP, CONDUCTED THOROUGH REVIEWS OF ALL PROPOSALS AND AWARDS WILL BE RELEASED IN MARCH 2013. THE PAUL PATTON CHARITABLE TRUST GRANTS FOR PEDIATRIC RESEARCH PROVIDED THREE GRANTS IN 2012. THE 2012 GRANTS WERE PRESENTED TO: 1) TIMOTHY FIELDS, KUMC, TREATMENTS TO SLOW PROGRESSION OF POLYCYSTIC KIDNEY DISEASE AND IMPROVE LONG-TERM SURVIVAL. 2) STEVEN KINGSMORE, CMH, IDENTIFYING GENE MUTATIONS CAUSATIVE IN PEDIATRIC GENETIC DISEASES AND TREATMENT DEVELOPMENT. 3) BRIAN PETROFF, KUMC, USE OF TAMOXIFEN TO POTENTIALLY DECREASE BIRTH DEFECTS. -MISSOURI SCIENCE AND INNOVATION REINVESTMENT ACT (MOSIRA). MOSIRA, MODELED AFTER THE SUCCESSFUL KEGA/KBA LEGISLATION IN KANSAS, WAS OVERWHELMINGLY PASSED BY BOTH THE HOUSE AND THE SENATE DURING A SPECIAL LEGISLATIVE SESSION AND THEN SIGNED INTO LAW BY GOVERNOR NIXON IN 2012. KCALSI, ALONG WITH MOBIO, THE KC CIVIC COUNCIL AND THE CHAMBER, PLAYED A ROLE AS PART OF THE STATE-WIDE MOSIRA COALITION TO EDUCATE AND ADVOCATE FOR MOSIRA PASSAGE. UNFORTUNATELY THE MISSOURI STATE SUPREME COURT DECLARED THE BILL UNCONSTITUTIONAL DUE TO A TECHNICAL DETAIL THE LINKAGE TO ANOTHER BILL THAT DID NOT PASS. FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE (CONTINUED): -PCORI WORKING GROUP OUTCOMES RESEARCH PAT JAMES, CHAIRMAN OF THE KCALSI BOARD OF DIRECTORS, CONVENED A BROAD GROUP OF ORGANIZATIONS WITH INTERESTS IN OUTCOMES RESEARCH TO DISCUSS A REGIONAL APPROACH TO COMPETING FOR FUNDING FROM THE PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI). THERE WAS AGREEMENT ON EXPLORING STRATEGIES FOR LEVERAGING LOCAL OUTCOMES RESEARCH ASSETS IN CARDIOVASCULAR MEDICINE INTO A SIGNIFICANT INFRASTRUCTURE CAPABLE OF SUPPORTING OUTCOMES RESEARCH IN A MUCH BROADER RANGE OF DISEASE CONDITIONS. KCALSI IS FACILITATING THE PROCESS AND ORGANIZED A WORKING GROUP COMPRISED OF REPRESENTATIVE STAKEHOLDERS IN OUTCOMES RESEARCH, IT, AND INSURERS. THE GROUP PROPOSED TWO INITIAL PILOT PROJECTS. -HIGH PERFORMANCE COMPUTING AND BIOINFORMATICS ASSESSMENT KCALSI FACILITATED DEVELOPMENT OF A BUSINESS PLAN FOR THE MID-CONTINENT ADVANCED COMPUTING CONSORTIUM AT THE REQUEST OF OUR INSTITUTIONAL ADVISORY BOARD. PARTNERS IN THE EFFORT INCLUDE THE UNIVERSITY OF MISSOURI SYSTEM, KANSAS STATE UNIVERSITY AND THE UNIVERSITY OF KANSAS. AS POTENTIAL FUNDING SOURCES FOR THE PROJECT, THE UNIVERSITY OF MISSOURI SUBMITTED AN EPSCOR TRACK I PROPOSAL TO THE NATIONAL SCIENCE FOUNDATION AND THE UNIVERSITY OF KANSAS SUBMITTED AN EPSCOR TRACK II PROPOSAL THAT INCLUDED THE UNIVERSITY OF MISSOURI. THE COMBINED APPLICATIONS REPRESENT $28 MILLION IN POTENTIAL FUNDING OVER 4 YEARS. ADDITIONALLY, KCALSI ADMINISTERED A BIOINFORMATICS ASSET MAPPING PROJECT THAT WAS FUNDED BY THE KAUFFMAN FOUNDATION. THE FOCUS OF THE PROJECT WAS TO QUANTIFY THE BIOINFORMATICS RESOURCES IN THE REGION, BENCHMARK WITH OTHER REGIONS, AND IDENTIFY SIGNIFICANT STRENGTHS, WEAKNESSES AND OPPORTUNITIES IN BIOINFORMATICS INFRASTRUCTURE. THE FINAL REPORT IS IN DEVELOPMENT AND WILL BE DISSEMINATED AMONG REGIONAL PARTNERS. -DIGITAL SANDBOX THE GOAL OF THE DIGITAL SANDBOX IS TO SIGNIFICANTLY ACCELERATE THE DEVELOPMENT OF IT-ORIENTED STARTUPS IN KANSAS CITY, WHERE IT IS ALREADY A MAJOR ECONOMIC ENGINE. THE PROJECT WILL GENERATE 10 NEW COMPANIES WITH AT LEAST $1 MILLION IN REVENUE OR SIGNIFICANT FOLLOW-ON INVESTMENT WITHIN TWO YEARS OF THE LAUNCH. UMKC PARTNERED WITH PRIVATE SECTOR COMPANIES WHO ARE CONTRIBUTING FINANCIAL AND PERSONNEL RESOURCES, INCLUDING SPRINT, HALLMARK, VML, RAREWIRE, CERNER, SPARKLABKC AND UMB. MORE PRIVATE SECTOR PARTNERS ARE EXPECTED TO JOIN THE CONSORTIUM. KCALSI IS A KEY PARTNER IN ORGANIZING AND EXECUTING APPLICANT SUBMISSIONS AND SELECTION FOR PARTICIPATING IN THE DIGITAL SANDBOX. THE ECONOMIC DEVELOPMENT ADMINISTRATION $1 M GRANT WAS MATCHED WITH $500,000 FROM MTC AND $500,000 IN CASH AND IN-KIND FROM INDUSTRY PARTNERS. THE DIGITAL SANDBOX ADDRESSES TWO IMMEDIATE GAPS IN THE ENTREPRENEURIAL ECOSYSTEM: CONNECTING LARGE INDUSTRY TO THE ENTREPRENEURIAL AND UNIVERSITY RESEARCH NETWORKS; AND PROVIDING EARLY-STAGE PROOF OF CONCEPT SUPPORT. SIGNIFICANT EVENTS AND COMMUNICATIONS: ON APRIL 10, OUR 2012 ANNUAL DINNER ENTITLED "BETTER, SMARTER, FASTER THE NEED FOR TRANSLATIONAL RESEARCH" FEATURED KEYNOTE SPEAKER DR. DAVID LIVINGSTON FROM THE DANA-FARBER CANCER INSTITUTE, WITH 550 PEOPLE IN ATTENDANCE. ON MAY 31, KCALSI AND FRONTIERS JOINTLY PRESENTED A SYMPOSIUM ENTITLED "BETTER, SMARTER, FASTER THE POWER OF COLLABORATION IN TRANSLATIONAL RESEARCH" FEATURING THREE NATIONAL SPEAKERS AND A PANEL ORGANIZED BY LESA MITCHELL FROM THE KAUFFMAN FOUNDATION ENTITLED "THE REINVENTION OF TRANSLATIONAL MEDICINE". OVER 170 SCIENTISTS AND ENTREPRENEURS ATTENDED THE TRANSLATIONAL MEDICINE SYMPOSIUM. ON AUGUST 27, WE HELD OUR ANIMAL HEALTH SYMPOSIUM ENTITLED "FAST FORWARD ACCELERATING INNOVATION TO COMMERCIALIZATION" FEATURING KEYNOTE SPEAKERS DR. GUY PALMER FROM WASHINGTON STATE UNIVERSITY AND DR. JAMES COOK FROM THE UNIVERSITY OF MISSOURI. OVER 160 PEOPLE ATTENDED FROM 16 STATES WITH EXTREMELY POSITIVE FEEDBACK RECEIVED ON THE SPEAKERS AND PRESENTATIONS. ON NOVEMBER 15, KCALSI, KANSASBIO AND MOBIO JOINTLY PRESENTED THE FIRST ANNUAL CRO SUMMIT ENTITLED "COLLABORATE, ACCELERATE, INNOVATE", FEATURING KEYNOTE SPEAKERS DR. MARY JO LAMBERTI, FROM THE TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT; JOAN CHAMBERS, FROM CENTER WATCH AND DR. SCOTT WEIR, DIRECTOR OF THE INSTITUTE FOR ADVANCING MEDICAL INNOVATION, KU CANCER CENTER. OUR COMMUNICATIONS ARE FOCUSED ON EDUCATING THE REGION ABOUT IMPORTANT DEVELOPMENTS AT OUR STAKEHOLDERS AND IN THE REGION. THEY OFTEN SERVE AS A POINT OF ENTRY FOR PEOPLE, ORGANIZATIONS OR COMPANIES INTERESTED IN EXPLORING THE REGION FOR POTENTIAL COLLABORATIONS. FORM 990, PART VI, SECTION B, LINE 11 THE ORGANIZATION HAS A POLICY FOR THE ORGANIZATION'S AUDIT COMMITTEE TO REVIEW THE 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ALL STAFF AND DIRECTORS MUST SUBMIT ANY CONFLICTS OF INTEREST ON AN ANNUAL BASIS. IF A CONFLICT ARISES WITHIN THE BOARD, THE DISCLOSING INDIVIDUAL SHALL NEITHER VOTE NOR ENDEAVOR TO INFLUENCE THE DECISION. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION OF THE ORGANIZATION'S PRESIDENT IS AGREED UPON BY THE BOARD OF DIRECTORS AND FINALIZED VIA A WRITTEN EMPLOYMENT CONTRACT. THIS APPROVAL IS DOCUMENTED IN THE MINUTES OF THE BOARD. IN 2013 THE ORGANIZATION CREATED A COMPENSATION COMMITTEE AND HAS PLANNED A COMPENSATION STUDY TO FURTHER REFINE THE COMPENSATION PROCESS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE ONLY AVAILABLE UPON REQUEST. OTHER FEES FORM 990, PART IX, LINE 11G OTHER FEES: PROGRAM SERVICE EXPENSES 160,455. MANAGEMENT AND GENERAL EXPENSES 57,809. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 218,264. KC BIO HOLDINGS INC 30 W PERSHING ROAD STE 210 KANSAS CITY MO 64108 412115941 LIFE SCIENCES MO N/A C 1.00000 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0